Zagreb, Croatia

Slobodan Djokic

This inventor holds 11 USPTO granted patents, plus 1 CIPO patent. Top assignees: Pliva Pharmaceutical and Chemical Works, Sour Pliva, Pliva Farmaceutska. Active years: 1976-1996.


% Patents Active = 100.0


Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 204(Granted Patents)


Company Filing History:


Years Active: 1976-1996

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Slobodan Djokic

Introduction

Slobodan Djokic is a notable inventor based in Zagreb, YU. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work primarily focuses on the development of new compounds and their applications in medical treatments.

Latest Patents

Among his latest patents, Djokic has developed complexes and chelates of azithromycin with bivalent and/or trivalent metals. This invention relates to the use of these complexes in antiulcer drugs, as well as the processes for obtaining them. Another significant patent involves oleandomycin oximes, which includes a process for their preparation and their use in antimicrobial agents. These innovations highlight his commitment to advancing medical science through his research.

Career Highlights

Throughout his career, Slobodan Djokic has worked with prominent companies such as Pliva Pharmaceutical and Chemical Works and Sour Pliva. His experience in these organizations has allowed him to refine his skills and contribute to various pharmaceutical advancements.

Collaborations

Djokic has collaborated with several professionals in his field, including Gabrijela Kobrehel and Zrinka Tamburasev. These partnerships have played a crucial role in the development of his innovative ideas and patents.

Conclusion

Slobodan Djokic's contributions to the pharmaceutical industry through his patents and collaborations demonstrate his dedication to innovation and improvement in medical treatments. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…